已收盤 09-19 16:00:00 美东时间
+1.080
+1.87%
Cantor Fitzgerald analyst Kristen Kluska reiterates Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Overweight and maintains $116 price target.
09-17 00:57
In a report released today, Tazeen Ahmad from Bank of America Securities mainta...
09-16 21:15
Tactical Resources Corp. (TSE:RARE) has released an update. Tactical Resources ...
08-30 03:10
文章转载来源: WolfDAO 快速阅读(详细解读见下方) 行情景气指数:75(前值)→75(现值) 利多因素: 市场信心仍存,看涨期权筹码结构依然稳定 上方高...
08-27 10:39
Tactical Resources Corp. (TSE:RARE) has released an update. Tactical Resources ...
08-24 03:37
Mereo BioPharma Group press release (NASDAQ:MREO): Q2 GAAP EPS of -$0.02. As of June 30, 2024, the Company had cash and cash equivalents of $87.4 million, compared to $57.4 million as of December 31, ...
08-13 21:03
Ultragenyx Pharmaceutical Inc : Citigroup Cuts Target Price to $111 From $118
08-13 18:23
We wouldn't blame Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) shareholders if ...
08-09 18:31
Ultragenyx Pharmaceutical Inc : Guggenheim Raises Target Price to $64 From $55
08-05 18:29
Ultragenyx Pharmaceutical Inc. : Wells Fargo Raises Target Price to $75 From $72
08-02 19:28